| Financial Year |
March 31 2023 |
| Monetary Funds |
1,798,184,574.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
464,735,640.15 |
| Accounts Receivable |
734,870,652.56 |
| Advances to Suppliers |
49,038,895.75 |
| Other Receivables |
185,222,153.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
99,509,881.82 |
| Inventories |
562,335,253.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
46,275,917.11 |
| Total Current Assets |
3,840,663,087.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,407,756,199.14 |
| Investment Properties |
-- |
| Fixed Assetes |
1,508,682,992.22 |
| Under-construction Projects |
100,535,225.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
4,116,487.37 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
483,010,519.64 |
| R&D expenses |
-- |
| Goodwill |
456,515,946.80 |
| Long-Term Deferred and Prepaid Expenses |
47,297,878.13 |
| Deferred Income Tax Assets |
49,035,171.78 |
| Other Non-Current Assets |
118,446,927.38 |
| Sub-Total of Non-Current Assets |
4,234,269,767.44 |
| Total Assets |
8,074,932,854.92 |
| Short-Term Loans |
15,517,477.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
593,688,910.40 |
| Accounts Payable |
359,718,130.25 |
| Accounts Received In Advance |
132,035.27 |
| Employee Compensation Payable |
47,369,083.82 |
| Taxes Payable |
37,401,925.68 |
| Interest Payable |
-- |
| Dividend Payable |
12,537,743.12 |
| Other payables |
32,357,706.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
42,159,840.31 |
| Other Current Liabilities |
41,937,221.46 |
| Sub-Total of Current Liabilities |
1,177,963,689.94 |
| Long-term Loans |
10,000,000.00 |
| Bonds Payable |
269,441,868.09 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
291,377,001.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
678,045,990.35 |
| Total Liabilities |
1,856,009,680.29 |
| Paid-In Capital(Or Share Stock) |
1,842,960,614.00 |
| Capital Surplus |
686,665,060.71 |
| Surplus Reserve |
672,340,692.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,550,160,758.87 |
| Minority Stockholder's Interest |
424,314,406.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,794,608,767.66 |
| Owner's Equity（Stockholder's Equity） |
6,218,923,174.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,074,932,854.92 |
